Clinical Trials Browser

Phase EARLY_PHASE1 × Imatinib Mesylate × 1 year × Clear all

NCT05816785 2025-09-03

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Phase EARLY_PHASE1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms